Main Article Content
Contralateral Breast Lymphoma, Breast Cancer, Breast Diffuse B Cell Lymphoma, Breast MALT lymphoma
Background: Breast involvement during malignant lymphomas is a rare condition, whether in primary or secondary cases, whereas according to the literature, primary breast lymphomas represents merely less than 0.5% of the breast malignancies.
Case Presentation: The case was a 48 years-old patient referred to the clinic with contralateral breast diffuse large B cell malignant lymphoma. She had an operation for right breast mucosa-associated lymphoma tissue (MALT) lymphoma two-years earlier. The participant experienced surgical excision of the right breast mass and radiotherapy subsequently. Surprisingly, after two years she developed a mass on the left breast, for which we were not able to establish an evident relationship between the earlier MALT lymphoma and the second diffused B cell lymphoma.
Conclusion: Although, our report emphasizes on the undeniable role of the breast examination in prevention of catastrophic events, we are far from providing diagnostic approaches on breast MALT lymphoma, due to minimal case sizes and lack of adequate information and evidences.
2. Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, et al. Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site. British journal of haematology. 2014;165(1):67-77.
3. Gopal S, Awasthi S, Elghetany M. Bilateral breast MALT lymphoma: a case report and review of the literature. Annals of hematology. 2000;79(2):86-9.
4. Mattia AR, Ferry JA, Harris NL. Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. The American journal of surgical pathology. 1993;17(6):574-87.
5. Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer treatment reviews. 2014;40(8):900-8.
6. Eberl MM, Fox CH, Edge SB, Carter CA, Mahoney MC. BI-RADS Classification for Management of Abnormal Mammograms. The Journal of the American Board of Family Medicine. 2006;19(2):161-4.
7. Topalovski M, Crisan D, Mattson JC. Lymphoma of the Breast. Archives of Pathology & Laboratory Medicine. 1999;123(12):1208-18.
8. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa‐associated lymphoid tissue. Cancer. 1984;53(11):2515-24.
9. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. Journal of Clinical Oncology. 1998;16(8):2780-95.
10. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, et al. Helicobacter pylori infection and gastric lymphoma. New England Journal of Medicine. 1994;330(18):1267-71.
11. Albano D, Bosio G, Giubbini R, Bertagna F. 18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation. Leukemia & lymphoma. 2017;58(10):2328-34.
12. Belfeki N, Bellefquih S, Bourgarit A. Breast MALT lymphoma and AL amyloidosis complicating Sjögren’s syndrome. BMJ Case Reports CP. 2019;12(4):e227581.
13. Hakoda Y, Gotoh A, Kuriyama Y, Kusama M, Koyanagi Y, et al. Breast MALT lymphoma: potential relationship between hormonal environment and female sex hormone receptor expression in lymphoma cells. Taylor & Francis; 2001.
14. Kim D-H, Jeong JY, Lee S-W, Lee J, Ahn B-C. 18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma. Clinical nuclear medicine. 2015;40(2):e148-9.
15. Caon J, Wai ES, Hart J, Alexander C, Truong PT, et al. Treatment and outcomes of primary breast lymphoma. Clinical breast cancer. 2012;12(6):412-9.